🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 71723F103
- Market Cap
- Micro Cap · $3 Million
- IPO
- 5/18/2016 · $5.00/share
- Previous Symbol
- PZRX
Business: PhaseRx, Inc. is a preclinical biopharmaceutical company dedicated to developing products for the treatment of inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy (i-ERT). The Company’s i-ERT approach is enabled by its proprietary Hybrid mRNA Technology platform.
Company Contact
- CEO
- Robert W. Overell, Ph.D.
- VPF
- Helen Tsui
- Headquarters
- 410 W. Harrison Street, Suite 300, Seattle, WA 98119
- Phone
- 206-805-6300
- Investor Relations
- Robert H. Uhl, Westwicke Partners · 858-356-5932 · robert.uhl@westwicke.com